| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
HSPG2 |
HSPG2: Basement membrane-specific heparan sulfate proteoglycan core protein prec |
0.295 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.295 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.295 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
0.295 |
Evidence |
|
| MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
0.295 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CRLF3 |
IPI00295387 |
0.295 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
IL10RA |
IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor |
0.295 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
0.295 |
Evidence |
|
| ITGB4 |
IPI00027422 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.295 |
Evidence |
|
| ITGB4 |
IPI00027422 |
COL7A1 |
COL7A1: Collagen alpha-1(VII) chain precursor |
0.295 |
Evidence |
|
| CD44 |
IPI00305064 |
FGL2 |
FGL2: Fibroleukin precursor |
0.295 |
Evidence |
|
| CD44 |
IPI00305064 |
CFP |
CFP, PFC: Properdin precursor |
0.295 |
Evidence |
|
| AREG |
AREG, SDGF: Amphiregulin precursor |
COL7A1 |
COL7A1: Collagen alpha-1(VII) chain precursor |
0.295 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.295 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
LILRB1 |
IPI00385703 |
0.295 |
Evidence |
|
| VIL2 |
IPI00479359 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.295 |
Evidence |
|
| VIL2 |
IPI00479359 |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.295 |
Evidence |
|
| VIL2 |
IPI00479359 |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.295 |
Evidence |
|
| IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.295 |
Evidence |
|
| IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
STK38L |
STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like |
0.295 |
Evidence |
|
| IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
DOK1 |
DOK1: Docking protein 1 |
0.295 |
Evidence |
|
| IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.295 |
Evidence |
|
| IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.295 |
Evidence |
|
| IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
0.295 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.295 |
Evidence |
|